Navigation Links
-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
Date:3/6/2008

SEATTLE, March 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) will release its fourth quarter financial results on Thursday, March 13, 2008. Company management will host a conference call at 8:00 a.m. PT; 11:00 a.m. ET to review fiscal year 2007 financial results and provide 2008 financial guidance. Access to the discussion may be obtained as follows:

Time: 11:00 AM ET /8:00 AM PT

Date: March 13, 2008

Dial-in: 1-877-548-7901 (domestic) or +1-719-325-4844 (international)

Webcast: http://www.dendreon.com (homepage and investor relations

section)

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-888-203-1112 or +1-719-457-0820 for international callers; the conference ID number is 5074038. The replay will be available from 7:30 pm ET on Thursday, March 13 until 11:59 pm ET on Saturday, March 15. In addition the webcast will be archived for on-demand listening for 30 days at http://www.dendreon.com.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
2. VWR Funding, Inc. to Hold Fourth Quarter and Year-End 2007 Financial Results Conference Call
3. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
4. First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
5. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
6. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
7. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
8. SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
10. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
11. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast ... technology-focused strategy and M&A advisory firm. , This is an important step for Eaton ... Pacific healthcare innovators with capital and investors. , Popper and Company, founded in 2003 ...
(Date:5/15/2020)... ... , ... This new service offers clients a way to speak with Subject ... the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of ... OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am – ...
(Date:5/14/2020)... ... May 13, 2020 , ... In ... Lab: Optimizing Workflows in the Life Science Lab . The comprehensive information source ... from water purification and liquid handling to contamination control. , The content hub ...
(Date:5/5/2020)... PARIS (PRWEB) , ... May 05, 2020 , ... ... appointing a high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, ... Chemicals. , Holding a PhD in Immunology and being a Pharmacist, Xavier was involved ...
Breaking Biology Technology:
(Date:5/28/2020)... , ... May 28, 2020 ... ... has announced a new enzyme solution for adjunct liquefaction: AMYLEX® 6T. The ... the ability to expand into new segments with locally-sourced raw materials, improve ...
(Date:5/21/2020)... ... May 19, 2020 , ... ... provider of operations management solutions, today introduced BioMed to their award-winning computerized ... platform for connecting the people and systems around biomedical engineering to better ...
(Date:5/14/2020)... N.J. (PRWEB) , ... May ... ... SIMPLY – a platform that helps Life Science Manufacturers accurately and easily ... LAUNCH," automating the development of Gross-to-Net models by projecting discounts/rebates to Commercial ...
Breaking Biology News(10 mins):